The antibody-drug conjugates (ADC) market refers to the global industry that focuses on the development and commercialization of targeted cancer therapies that combine monoclonal antibodies with potent cytotoxic drugs. the market is anticipated to rising adoption of precision oncology & targeted therapeutics and advancements in linker, payload & conjugation technologies.
read more..